Commitment to Clinical Trial Data Transparency
As a science led biotech company, our clinical research is critical for the development of medicines for rare disease. We recognize the importance of sharing clinical trial data to advance science in order to serve the patients who use our medicines and the providers who prescribe them. We provide clinical trial data in a way that is consistent with patient privacy and data integrity that is consistent with applicable laws and regulations.
BioCryst registers clinical trial information and publishes summary results, regardless of outcome, in accordance with applicable laws and regulations on public registries including, Clinicaltrials.gov and European Clinical Trials Database (EudraCT). BioCryst encourages and seeks publication of registered clinical trial results in peer reviewed publications in a manner that ensures scientific accuracy and reflects applicable industry standards.
If you have any specific questions regarding BioCryst’s Clinical Trial Disclosure and Data Transparency commitment or practice, please contact us at email@example.com.